- Minodronic acid
-
Minodronic acid (1-Hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acidOther namesMinodronate; YM 529Identifiers CAS number 180064-38-4 , 155648-60-5 (hydrate) PubChem 130956 ChemSpider 115805 Jmol-3D images Image 1 - O=P(O)(O)C(O)(P(=O)(O)O)Cc1cnc2ccccn12
Properties Molecular formula C9H12N2O7P2 Molar mass 322.15 g mol−1 acid (verify) (what is: / ?)
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)Infobox references Minodronic acid is a third-generation bisphosphonate drug. It is approved for use in Japan for the treatment of osteoporosis.[1] Its mechanism of action involves inhibition of farnesyl pyrophosphate synthase activity.[2]
References
- ^ Shridhar Hegde and Michelle Schmidt (2009). "To Market, To Market - 2009. 16. Minodronic acid". Annual Reports in Medicinal Chemistry 45: 509–510.
- ^ Sorbera, L.A.; Castañer, J.; Leeson, P.A. (2002). "Minodronic Acid". Drugs of the Future 27 (10): 935–941. doi:10.1358/dof.2002.027.10.701186.
This pharmacology-related article is a stub. You can help Wikipedia by expanding it.